BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17142723)

  • 1. Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.
    Martin-Orozco N; Wang YH; Yagita H; Dong C
    J Immunol; 2006 Dec; 177(12):8291-5. PubMed ID: 17142723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.
    Keir ME; Freeman GJ; Sharpe AH
    J Immunol; 2007 Oct; 179(8):5064-70. PubMed ID: 17911591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade.
    Reynoso ED; Elpek KG; Francisco L; Bronson R; Bellemare-Pelletier A; Sharpe AH; Freeman GJ; Turley SJ
    J Immunol; 2009 Feb; 182(4):2102-12. PubMed ID: 19201863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.
    Fife BT; Pauken KE; Eagar TN; Obu T; Wu J; Tang Q; Azuma M; Krummel MF; Bluestone JA
    Nat Immunol; 2009 Nov; 10(11):1185-92. PubMed ID: 19783989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes.
    Keir ME; Latchman YE; Freeman GJ; Sharpe AH
    J Immunol; 2005 Dec; 175(11):7372-9. PubMed ID: 16301644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
    Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
    J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells.
    Goldberg MV; Maris CH; Hipkiss EL; Flies AS; Zhen L; Tuder RM; Grosso JF; Harris TJ; Getnet D; Whartenby KA; Brockstedt DG; Dubensky TW; Chen L; Pardoll DM; Drake CG
    Blood; 2007 Jul; 110(1):186-92. PubMed ID: 17392506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model.
    Lukens JR; Cruise MW; Lassen MG; Hahn YS
    J Immunol; 2008 Apr; 180(7):4875-84. PubMed ID: 18354211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy.
    Tsushima F; Yao S; Shin T; Flies A; Flies S; Xu H; Tamada K; Pardoll DM; Chen L
    Blood; 2007 Jul; 110(1):180-5. PubMed ID: 17289811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.
    Carter L; Fouser LA; Jussif J; Fitz L; Deng B; Wood CR; Collins M; Honjo T; Freeman GJ; Carreno BM
    Eur J Immunol; 2002 Mar; 32(3):634-43. PubMed ID: 11857337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism.
    Matsumoto K; Inoue H; Nakano T; Tsuda M; Yoshiura Y; Fukuyama S; Tsushima F; Hoshino T; Aizawa H; Akiba H; Pardoll D; Hara N; Yagita H; Azuma M; Nakanishi Y
    J Immunol; 2004 Feb; 172(4):2530-41. PubMed ID: 14764726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver.
    Maier H; Isogawa M; Freeman GJ; Chisari FV
    J Immunol; 2007 Mar; 178(5):2714-20. PubMed ID: 17312113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
    J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.
    Lucas CL; Workman CJ; Beyaz S; LoCascio S; Zhao G; Vignali DA; Sykes M
    Blood; 2011 May; 117(20):5532-40. PubMed ID: 21422469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis.
    Zhu B; Guleria I; Khosroshahi A; Chitnis T; Imitola J; Azuma M; Yagita H; Sayegh MH; Khoury SJ
    J Immunol; 2006 Mar; 176(6):3480-9. PubMed ID: 16517716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model.
    Durgan K; Ali M; Warner P; Latchman YE
    Cancer Immunol Immunother; 2011 Apr; 60(4):547-58. PubMed ID: 21240487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway.
    Haspot F; Fehr T; Gibbons C; Zhao G; Hogan T; Honjo T; Freeman GJ; Sykes M
    Blood; 2008 Sep; 112(5):2149-55. PubMed ID: 18577709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo.
    Sandner SE; Clarkson MR; Salama AD; Sanchez-Fueyo A; Domenig C; Habicht A; Najafian N; Yagita H; Azuma M; Turka LA; Sayegh MH
    J Immunol; 2005 Mar; 174(6):3408-15. PubMed ID: 15749874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.
    Hori J; Wang M; Miyashita M; Tanemoto K; Takahashi H; Takemori T; Okumura K; Yagita H; Azuma M
    J Immunol; 2006 Nov; 177(9):5928-35. PubMed ID: 17056517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.